9.80p-0.05 (-0.51%)12 Apr 2024, 16:29
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo

Poolbeg Pharma PLC Market & Company News

20.03.2024 16:18ROAD, PYX, POLBEARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stakeAlliance
20.03.2024 07:00POLBPOLB 001 US Patent UpdateRNS
22.02.2024 07:00POLBDirector/PDMR ShareholdingRNS
19.02.2024 13:42POLBDirector Share PurchaseRNS
15.02.2024 16:02DEC, POW, POLBTRADING UPDATES: Diversified Energy offers dividend alternativeAlliance
15.02.2024 07:00POLBBoard Role Change and Launch of EIPRNS
12.02.2024 19:44ATY, NTQ, KATTRADING UPDATES: Katoro Gold launches fundraising, eyes board shake-upAlliance
12.02.2024 07:00POLBMarket Opportunity for POLB 001 for CRSRNS
17.01.2024 13:58POLBPoolbeg Pharma hails POLB 001'S potential to treat CRSAlliance
17.01.2024 07:00POLBFurther data shows POLB001 potential in cancer CRSRNS
20.12.2023 20:00BELL, ADT1, RAITRADING UPDATES: K3 Business says cash balances ahead of forecastAlliance
20.12.2023 07:00POLBRSV AI Drug Candidate Analysis UpdateRNS
11.12.2023 07:00POLBPOLB 001 Data Presented at ASHRNS
30.11.2023 07:00POLBDirectorate ChangeRNS
21.11.2023 14:39TRR, DNE, UKOGTRADING UPDATES: Poolbeg hails approval; EDX links with Thermo FisherAlliance
21.11.2023 07:00POLBImmunomodulator II patent granted in JapanReach
16.11.2023 07:00POLBPOLB 001 LPS Trial Data to be Presented at IUISReach
09.11.2023 16:57POLBIN BRIEF: Poolbeg Pharma appoints former Amryt executives to teamAlliance
09.11.2023 07:00POLBFormer Amryt Pharma Leadership Team join PoolbegRNS
03.11.2023 07:05POLBPOLB001 Data to be Presented at ASH Annual MeetingRNS
01.11.2023 07:00POLBPOLB 001 Oncology Programme Update MeetingRNS
26.10.2023 07:00POLBSAB Endorses Influenza Drug TargetsReach
17.10.2023 10:49POLBPoolbeg Pharma shares up on metabolic drug collaboration agreementAlliance
17.10.2023 07:00POLBPoolbeg Partners with a Nasdaq-Listed BiopharmaRNS
02.10.2023 14:20CAV, OHG, OTV2EARNINGS AND TRADING: Kingswood cuts outlook; Poolbeg in patent joyAlliance
29.09.2023 07:00POLBFavourable Conclusion of Patent OppositionRNS
22.09.2023 20:37POLB, BMS, AGYTRADING UPDATES: Braemar investigation to end; Marula reports delayAlliance
20.09.2023 07:00POLBImmunomodulator I Patent Portfolio StrengthenedReach
19.09.2023 14:42UMR, BEG, COBRTRADING UPDATES: Chill Brands unphased by regulations; Cobra inks dealAlliance
19.09.2023 07:00POLBImmunomodulator I Patent Opposition WithdrawalRNS
13.09.2023 14:41PPHC, POLB, MTECEARNINGS: Frontier Developments turns to loss; Poolbeg optimisticAlliance
13.09.2023 07:00POLBInterim results for the six months to 30 June 2023RNS
29.06.2023 16:52POLBPoolbeg Pharma makes "significant" influenza breakthrough with AIAlliance
29.06.2023 07:00POLBAI led programme identifies influenza drug targetsRNS
22.06.2023 13:38POLBIN BRIEF: Poolbeg oral vaccination programme moves forwardAlliance
22.06.2023 07:00POLBOral Vaccine Programme Moves ForwardRNS
24.05.2023 07:00POLBBoard AppointmentRNS
11.05.2023 14:27POLBResults of Annual General MeetingRNS
04.05.2023 16:11WPS, VID, UPRUK shareholder meetings calendar - next 7 daysAlliance
12.04.2023 07:00POLBAnnual Report & AGM NoticeRNS
30.03.2023 07:00POLBResults for the year ended 31 December 2022RNS
10.03.2023 07:00POLBNotification of Major HoldingsRNS
09.03.2023 15:51SDR, POLBNotification of Major HoldingsRNS
08.03.2023 18:24MXC, MYX, SDXTRADING UPDATES: Poolbeg patent boost; Resolute Mining resource upAlliance
08.03.2023 07:00POLBPOLB 001 patent portfolio strengthenedReach
02.03.2023 14:47VTU, TXP, TLYTRADING UPDATES: Cordiant Digital hails portfolio firm's deal with AMCAlliance
02.03.2023 11:14VRCI, TLY, POLBAIM WINNERS & LOSERS: Metal Tiger goes into the Strata but out of AIMAlliance
02.03.2023 11:05POLBSecond Price Monitoring ExtnRNS
02.03.2023 11:00POLBPrice Monitoring ExtensionRNS
02.03.2023 07:00POLBPositive Results POLB001 LPS Human Challenge TrialRNS
16.01.2023 16:26ACPE, FARN, LBOWTRADING UPDATES: Tungsten West 'largest Western tungsten producer'Alliance
16.01.2023 07:00POLBStrategic expansion of POLB 001 into oncologyRNS
09.01.2023 14:14POLBPoolbeg Pharma says initial POLB 001 data shows positive response Alliance
09.01.2023 09:05POLBSecond Price Monitoring ExtnRNS
09.01.2023 09:00POLBPrice Monitoring ExtensionRNS
09.01.2023 07:00POLBPositive Initial Data Analysis in POLB 001 TrialRNS
22.12.2022 10:47POLBEQS-News: Poolbeg Pharma identifies new RSV drug candidatesEQS
21.12.2022 19:20POLB, CNR, GCATTRADING UPDATES: Atlantis Japan underperforms; Bellevue lowers payoutAlliance
21.12.2022 07:00POLBPoolbeg identifies novel RSV drug candidatesRNS
15.12.2022 09:48POLBEQS-News: Poolbeg Pharma makes 'interesting addition to existing collaboration'EQS
14.12.2022 21:54HE1, RMMC, AETTRADING UPDATES: Poolbeg acquires license; Afentra expects PSA delayAlliance
14.12.2022 07:00POLBMetabolic diseases oral delivery licence signedRNS
12.12.2022 14:05POLBSecond Price Monitoring ExtnRNS
12.12.2022 14:00POLBPrice Monitoring ExtensionRNS
12.12.2022 11:59POLBEQS-News: Poolbeg Pharma receives initial results from human challenge clinical studyEQS
12.12.2022 07:00POLBPOLB 001 LPS human challenge trial completedRNS
02.12.2022 19:33AST, SLE, ARVTRADING UPDATES: Time Out eyes Riyadh; MTI Wireless wins dealAlliance
29.11.2022 07:00POLBInfluenza AI model build completedReach
21.11.2022 11:35POLBEQS-News: Poolbeg Pharma wins first non-dilutive grant fundingEQS
18.11.2022 14:00POLBPrice Monitoring ExtensionRNS
17.11.2022 14:05POLBSecond Price Monitoring ExtnRNS
17.11.2022 14:00POLBPrice Monitoring ExtensionRNS
17.11.2022 07:00POLBCapital Markets DayRNS
15.11.2022 17:25POLBPoolbeg Pharma wins funding for oral vaccine developmentAlliance
15.11.2022 10:36POLBPoolbeg-led consortium awarded EUR 2.3m grantRNS
Showing 1 to 75 of 152